Does the intrinsic instability of aneuploid genomes have a causal role in cancer?

Trends in Genetics

Volumn 19, Issue 5, 2003, Pages 253-256

  Matzke, Marjori A ^a   Mette, M Florian ^a   Kanno, Tatsuo ^a   Matzke, Antonius J M ^a  

^a ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANEUGEN;

ANEUPLOIDY; AUTOSOME; CANCER INCIDENCE; CANCER RISK; CARCINOGENESIS; CHROMATIN STRUCTURE; CHROMOSOME 21; CHROMOSOME ABERRATION; CHROMOSOME BREAKAGE; CHROMOSOME DAMAGE; CHROMOSOME DELETION; CHROMOSOME NUMBER; CHROMOSOME REARRANGEMENT; CHROMOSOME STRUCTURE; CHROMOSOME TRANSLOCATION; CPG ISLAND; DNA METHYLATION; DNA MICROARRAY; DNA REPAIR; DNA STRAND BREAKAGE; GENE AMPLIFICATION; GENE DELETION; GENE DOSAGE; GENE EXPRESSION; GENE FREQUENCY; GENE INTERACTION; GENE MAPPING; GENE MUTATION; GENE OVEREXPRESSION; GENE SILENCING; GENE STRUCTURE; GENE TRANSLOCATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC REGULATION; GENETIC SUSCEPTIBILITY; GENOME; HUMAN; MITOSIS SPINDLE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SUPERNUMERARY CHROMOSOME; TRISOMY; TRISOMY 21; TUMOR SUPPRESSOR GENE; WHEAT;

ANEUPLOIDY; ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOME ABERRATIONS; DNA METHYLATION; GENE REARRANGEMENT; GENOME; HUMANS; NEOPLASMS; RECOMBINATION, GENETIC;

TRITICUM AESTIVUM;

EID: 0037406990     PISSN: 01689525     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-9525(03)00057-X     Document Type: Article

References (38)

1. Manchester K.L. Theodor Boveri and the origin of malignant tumors. Trends Cell Biol. 5:1995;384-387.
2. Schär P. Spontaneous DNA damage, genome instability, and cancer - when DNA replication escapes control. Cell. 104:2001;329-332.
3. Marx J. Debate surges over the origins of genomic defects in cancer. Science. 297:2002;544-546.
4. Lengauer C., et al. Genetic instabilities in human cancers. Nature. 396:1998;643-649.
5. Duesberg P., et al. How aneuploidy may cause cancer and genetic instability. Anticancer Res. 19:1999;4887-4906.
6. Sen S. Aneuploidy and cancer. Curr. Opin. Oncol. 12:2000;82-88.
7. Bishop J.M. Cancer: the rise of the genetic paradigm. Genes Dev. 9:1995;1309-1315.
8. Knudson A. Asbestos and mesothelioma: genetic lessons from a tragedy. Proc. Natl. Acad. Sci. U. S. A. 92:1995;10819-10820.
9. Khush G. Cytogenetics of Aneuploids. 1973;Academic Press.
10. Devos K., et al. Chromosome aberrations in wheat nullisomic-tetrasomic and ditelosomic lines. Cereal Res. Commun. 27:1999;231-239.
11. Jones R.N. B chromosomes in plants. New Phytol. 131:1995;411-434.
12. Dhar M., et al. Origin of an apparent B chromosome by mutation, chromosome fragmentation and specific DNA sequence amplification. Chromosoma. 111:2002;332-340.
13. Papp I., et al. Structural instability of a transgene locus in tobacco is associated with aneuploidy. Plant J. 10:1996;469-478.
14. Thiagalingam S., et al. Mechanisms underlying loses of heterozygosity in human colorectal cancers. Proc. Natl. Acad. Sci. U. S. A. 98:2001;2698-2702.
15. Wang J. DNA topoisomerases. Annu. Rev. Biochem. 65:1996;635-692.
16. Sperry A., et al. Dysfunction of chromosomal loop attachment sites: illegitimate recombination linked to matrix association regions and topoisomerase II. Proc. Natl. Acad. Sci. U. S. A. 86:1989;5497-5501.
17. Pomykala H., et al. Breakpoint junctions of chromosome 9p deletions in two human glioma cell lines. Mol. Cell. Biol. 14:1994;7604-7610.
18. Zhang Y., et al. Genomic DNA breakpoints in AML1/RUNX1 and ETO cluster with topoisomerase II DNA cleavage and DNase I hypersensitive sites in t(8;21) leukemia. Proc. Natl. Acad. Sci. U. S. A. 99:2002;3070-3075.
19. Fodde R., Smits R. A matter of dosage. Science. 298:2002;761-763.
20. Hoeijmakers J. Genome maintenance mechanisms for preventing cancer. Nature. 411:2001;366-373.
21. Jones P., Baylin S. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3:2002;415-428.
22. Hsieh J., Fire A. Recognition and silencing of repeated DNA. Annu. Rev. Genet. 34:2000;187-204.
23. Kuromitsu J., et al. A unique downregulation of h2-calponin gene expression in Down syndrome: a possible attenuation mechanism for fetal survival by methylation at the CpG island in the trisomic chromosome 21. Mol. Cell. Biol. 17:1997;707-721.
24. Yu J., et al. Gene identification and DNA sequence analysis in the GC-poor 20 megabase region of human chromosome 21. Proc. Natl. Acad. Sci. U. S. A. 94:1997;6862-6867.
25. FitzPatrick D., et al. Transcriptome analysis of human autosomal trisomy. Hum. Mol. Genet. 11:2002;3249-3256.
26. Guo M., Birchler J. Trans-acting dosage effects on the expression of model gene systems in maize aneuploids. Science. 266:1994;1999-2002.
27. Hernandez D., Fisher E. Mouse autosomal trisomy, two's company, three's a crowd. Trends Genet. 15:1999;241-247.
28. Reeves R., et al. Too much of a good thing: mechanisms of gene action in Down syndrome. Trends Genet. 17:2001;83-88.
29. Hattori M., et al. The DNA sequence of human chromosome 21. Nature. 405:2000;311-319.
30. Shen J., et al. Cytogenetic and molecular studies of Down syndrome individuals with leukemia. Am. J. Hum. Genet. 56:1995;915-925.
31. Drabkin H., Erickson P. Down syndrome and leukemia, an update. Prog. Clin. Biol. Res. 393:1995;169-176.
32. Ma S., et al. Characterization of additional genetic events in childhood acute lymphoblastic leukemia with TEL/AML1 gene fusion: a molecular cytogenetics study. Leukemia. 15:2001;1442-1447.
33. Hasle H., et al. Risks of leukaemia and solid tumors in individuals with Down's syndrome. Lancet. 355:2000;165-169.
34. Satgé D. Another reason to look for tumor suppressor genes on chromosome 21. Genes Chromosomes Cancer. 21:1998;1.
35. Gisler B., et al. The role of double-strand break-induced allelic homologous recombination in somatic plant cells. Plant J. 32:2002;277-284.
36. Nigg E. Centrosome aberrations: cause or consequence of cancer progression? Nat. Rev. Cancer. 2:2002;815-825.
37. Masuda A., Takahashi T. Chromosome instability in human lung cancers: possible underlying mechanisms and potential consequences in the pathogenesis. Oncogene. 21:2002;6884-6897.
38. Anderson G., et al. Cancer: the evolved consequence of a destabilized genome. BioEssays. 23:2001;1037-1046.